Outbreaks- HIV/AIDS, STDs & STIs

The rate of securing of viral STDs is expanding, and most popular contaminations can't be cured by medications. Information from the World Health Organization (WHO, 2015b) assess a worldwide figure of around 35 million individuals who are living with the human immunodeficiency infection (HIV). Similar information demonstrate around 1,370,000 passings by (AIDS) worldwide in the nations reporting information (prominently, the United States and China are excluded in the reported information) (WHO, 2015b). Be that as it may, the sickness movement in HIV/AIDS can be impeded by antiretroviral drugs (Bichoupan and Dieterich, 2014), and the recurrence of episodes can be diminished by antiviral medications, as on account of herpes simplex infection (HSV). Amid the essential disease, and once in a while amid intermittent episodes, herpes simplex infection can bring about cervicitis that incorporates vesicles and ulcers. There is generally no mucopurulent exudate with herpes cervicitis. 

  • Basic retro-virology, HIV structutre, function, pathogenesis
  • 3-2HIV related Infections and coinfections
  • New therapeutic approaches
  • Therapeutic antibodies, gene switches, and enzymes
  • Immunotoxins and immune-based therapies for target reservoirs of HIV-infected cells

Related Conference of Outbreaks- HIV/AIDS, STDs & STIs

May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland
October 24-25, 2024

5th International Conference on Immunology And Immunotherapy

Zurich, Switzerland

Outbreaks- HIV/AIDS, STDs & STIs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in